Filing Flows › Insmed (INSM) › BRINSUPRI revenue
Insmed (INSM) BRINSUPRI revenue by quarter
Insmed's BRINSUPRI revenue was $400M in Q3 2026 (third quarter 2026), +29% from Q2 2026. Over the last 5 quarters it ranged from $28.1M (Q3 2025) to $400M (Q3 2026).
| Quarter | BRINSUPRI revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $400M | +29% | 14× |
| Q2 2026 | $309M | +49% | — |
| Q1 2026 | $208M | +44% | — |
| Q4 2025 | $145M | +416% | — |
| Q3 2025 | $28.1M | — | — |
Q3 2026 at a glance
Insmed, Q3 2026: revenue $524M (+268% year over year), operating margin -17.0%, net loss $100M, operating cash flow −$36.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is Insmed's BRINSUPRI revenue?
Insmed's BRINSUPRI revenue was $400M in Q3 2026 (third quarter 2026), +29% from Q2 2026.
How has Insmed's BRINSUPRI revenue changed?
Over the last 5 quarters it ranged from $28.1M (Q3 2025) to $400M (Q3 2026).